Latest filing published 21 Sept 2026 for NovaBridge Biosciences.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Phillip Andrew Dennis: trading record in brief
Phillip Andrew Dennis appears in our data through filings on NovaBridge Biosciences shares, published by SEC (Form 4). Between 17 June 2026 and 18 September 2026, the trades on record add up to 4 filings.
Sales make up the whole of the open-market record (2 sales, €9,969). Other entries cover 2 option exercises.
The latest filing, published on 21 September 2026, reports an option exercise in NovaBridge Biosciences. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Phillip Andrew Dennis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,695 sharesOrdinary SharesSEC:0002089237-26-000008:0
- 8,209 shares@ US$0.71Ordinary SharesSEC:0002089237-26-000008:1
- 23,695 sharesOrdinary SharesSEC:0002089237-26-000006:0
- 8,494 sharesOrdinary SharesSEC:0002089237-26-000006:1
4 of 4 declarations